NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that revenues during the third quarter increased 13 percent year over year as the Human Health segment grew 24 percent.

The company reported revenues of $509.6 million for the three months ended Sept. 30, up from $452.9 million a year ago, surpassing the consensus Wall Street estimate of $505.5 million. Human Health revenues rose to $257.2 million, up from $206.6 million, while Environmental Health revenues grew 2 percent to $252.4 million from $246.3 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.

Apr
03
Sponsored by
Dovetail Genomics

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.